Earnings analysis · 10-Q
REF earnings analysis
Filed September 11, 2026 · Our reading of the company's report
The latest report
Reformation delivered Q2 revenue of $155.2 million and diluted EPS of $0.23, exceeding consensus estimates of $154.5 million and $0.22, respectively. Revenue increased approximately 24.1% from $125.1 million in Q2 2025,…
Read full summary
Reformation delivered Q2 revenue of $155.2 million and diluted EPS of $0.23, exceeding consensus estimates of $154.5 million and $0.22, respectively. Revenue increased approximately 24.1% from $125.1 million in Q2 2025, while gross margin reached 66.7% and adjusted EBITDA margin was 16.4%. Liquidity was supported by $76.6 million of cash and $26.4 million of revolver capacity, but leverage remained elevated at $250.3 million and three internal-control material weaknesses were not yet remediated. Fiscal 2026 revenue outlook was $602 million to $606 million, but guidance direction versus the prior outlook was not provided.
Reported figures
- Earnings per share
- $0.23
- Gross margin
- 66.7%
What stood out
-
Revenue grew 24% and beat estimates
Q2 revenue was $155.2 million, up from $125.1 million in Q2 2025, an increase of approximately 24.1%. Revenue also exceeded the $154.5 million consensus estimate by approximately $0.8 million.
-
EPS exceeded consensus
Diluted EPS was $0.23 versus the $0.22 consensus estimate, a $0.01 beat or approximately 4.6%. The filing text provided does not disclose a prior-period EPS comparison.
-
Margins expanded
Gross margin expanded to 66.7%, while adjusted EBITDA margin increased to 16.4%, according to the reported quarterly results. The filing text provided does not include the prior-period margin percentages needed to quantify the year-over-year change.
-
IPO proceeds reduced term debt
The company completed its IPO at $15.00 per share and received approximately $125.7 million of net proceeds. It used $110.0 million to partially repay term loans and $8.5 million to repurchase shares and options.
-
Liquidity remained available
Cash and cash equivalents were $76.6 million as of June 27, 2026. The company also had $26.4 million of capacity available under its revolving facility, which was not utilized.
What to watch
-
Unremediated internal-control weaknesses
Management concluded that disclosure controls were not effective because three material weaknesses in internal control over financial reporting remained unremediated as of June 27, 2026. Remediation efforts were still in progress, creating risk of reporting errors and investor-confidence damage.
-
High leverage and rate exposure
Total indebtedness was $250.3 million as of June 27, 2026, comprising $246.7 million of term loans and $3.6 million of letters of credit, versus $76.6 million of cash. A 100-basis-point increase in interest rates would reduce quarterly net profit by $1.8 million, although the revolving facility was not utilized.
-
Large pre-IPO dividend reduced liquidity
The company paid an aggregate cash dividend of approximately $90 million in June 2026 before the IPO, while its Credit Agreement restricts certain dividends. This reduced liquidity before the company used $110.0 million of IPO proceeds to repay term loans.
-
Tariff and sourcing uncertainty
Tariff exposure remains material: approximately 32% of finished goods were affected by U.S. tariffs on China imports in 2025, despite shifting approximately 20% of production capacity from China to Vietnam, the United States and Mexico. The filing also cites a potential 50% tariff on certain Canadian products effective August 19, 2026.
-
Wholesale counterparty concentration
Wholesale and receivables concentration creates counterparty risk. Saks Global's Chapter 11 bankruptcy resulted in a $1.7 million expense in 2025, and a single customer represented 23% of consolidated accounts receivable as of 2025.
-
Concentrated global supply chain
Supplier concentration remains significant: the top five suppliers produced approximately 54% of units in 2025 and the top ten produced approximately 76%. The company also remained dependent on China for approximately 32% of units after reducing single-country exposure by 19%.
Management's outlook
The filing does not provide comparable prior guidance, so the direction cannot be determined. Fiscal 2026 outlook previously disclosed with net revenue of $602 million to $606 million, adjusted EBITDA margin of 14.0% to 14.2%, and capital expenditures of approximately $23 million to $27 million.
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.